Neumora Therapeutics Inc (NASDAQ: NMRA) kicked off on Monday, up 14.29% from the previous trading day, before settling in for the closing price of $2.17. Over the past 52 weeks, NMRA has traded in a range of $1.83-$21.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 55.97%. With a float of $55.17 million, this company’s outstanding shares have now reached $160.48 million.
The firm has a total of 124 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Neumora Therapeutics Inc (NMRA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Neumora Therapeutics Inc is 65.85%, while institutional ownership is 29.80%. The most recent insider transaction that took place on Oct 18 ’24, was worth 239,319. In this transaction Director of this company sold 14,049 shares at a rate of $17.03, taking the stock ownership to the 20,100 shares. Before that another transaction happened on Oct 17 ’24, when Company’s Director sold 7,739 for $17.01, making the entire transaction worth $131,643. This insider now owns 20,100 shares in total.
Neumora Therapeutics Inc (NMRA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.97% per share during the next fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Take a look at Neumora Therapeutics Inc’s (NMRA) current performance indicators. Last quarter, stock had a quick ratio of 10.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.85, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.61 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
Analysing the last 5-days average volume posted by the [Neumora Therapeutics Inc, NMRA], we can find that recorded value of 16.44 million was lower than the volume posted last year of 26.79 million. As of the previous 9 days, the stock’s Stochastic %D was 3.87%. Additionally, its Average True Range was 1.23.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 4.23%, which indicates a significant decrease from 6.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 698.28% in the past 14 days, which was higher than the 276.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.40, while its 200-day Moving Average is $11.25. Now, the first resistance to watch is $2.65. This is followed by the second major resistance level at $2.82. The third major resistance level sits at $3.05. If the price goes on to break the first support level at $2.25, it is likely to go to the next support level at $2.02. Now, if the price goes above the second support level, the third support stands at $1.85.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
The company with the Market Capitalisation of 400.67 million has total of 161,561K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -235,930 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -72,550 K.